| CAS ID: | 81103-11-9 |
| Molecular Formula: | C38H69NO13 |
| Molecular Weight: | 748 g/mol |
| Monoisotopic Mass: | 747.4769 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | TE-031 | FEBZIN XL | CLAROSIP | CLARITHROMYCIN | ABBOTT-56268 | Biaxin | Prevpac | KLARICID ADULT | BIAXIN XL | A-56268 | Clarithromycin extended release | MYCIFOR XL | KLARICID PAED | CLARIE XL | Biaxin XL Pac | XETININ XL | KLARICID XL | KLARICID | ZECLAR | KLARICID I.V. | KLARICID 500 |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1 | See All |
| InChI Key: | AGOYDEPGAOXOCK-KCBOHYOISA-N | |
| Smiles: | CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00205634 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | September 20, 2005 | Last Verified | August 13, 2018 |
| Sponsor | Wake Forest University | ||
| PubChem: | 84029 |
| ChEMBL: | CHEMBL1741 |